Aura Biosciences, Inc.

XNAS

Last traded price · USD

$6.65

+6.57%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: $6.42
Previous close: $6.24
Volume: 1.0M
Day's high: $6.66
Day's low: $6.26

In brief

Aura Biosciences, Inc. is a US-listed company listed on Nasdaq, valued at about $690M.
Its shares closed at $6.65 on 4 Nov 2026, up 17.1% over the past year.
From India you can buy AURA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Aura Biosciences, Inc. (AURA) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole AURA share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade AURA options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

10.6 days to cover short interest
10.9M shares were sold short at the 15 Oct 2026 settlement, 10.5% of the 103.7M shares outstanding; covering them would take 10.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $6.65 was 0.9% above its 50-day average ($6.59) and 1.3% below its 200-day average ($6.74). It has closed below the 200-day for 35 sessions, since 17 Sep 2026. The 50-day average crossed below the 200-day on 30 Oct 2026, 3 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Ahead of SPY over 1 year
1 month: +7.8% (SPY −1.6%). 3 months: −7.4% (SPY −0.4%). 1 year: +17.1% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: AURA, SPY · as of 4 Nov 2026
40% of the way up its 52-week range
Closed at $6.65 on 4 Nov 2026: 30.3% below the 52-week high of $9.54 (5 May 2026) and 40.6% above the low of $4.73 (20 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+7.8%

6 months−19.8%

1 year+17.1%

5 years−63.7%

Newswire

About

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Website

Notable moves

November 7, 2023
−32.55%
November 29, 2021
−21.53%
November 16, 2021
+20.24%

Aura Biosciences, Inc.

XNAS

Last traded price · USD

$6.65

+6.57%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: $6.42
Previous close: $6.24
Volume: 1.0M
Day's high: $6.66
Day's low: $6.26

In brief

Aura Biosciences, Inc. is a US-listed company listed on Nasdaq, valued at about $690M.
Its shares closed at $6.65 on 4 Nov 2026, up 17.1% over the past year.
From India you can buy AURA in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Aura Biosciences, Inc. (AURA) shares from India?

Do I need the price of a whole AURA share to invest?

How much can I invest in US stocks in a year?

Can I trade AURA options or futures?

Insights

Quotes run fifteen minutes behind.

10.6 days to cover short interest
10.9M shares were sold short at the 15 Oct 2026 settlement, 10.5% of the 103.7M shares outstanding; covering them would take 10.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $6.65 was 0.9% above its 50-day average ($6.59) and 1.3% below its 200-day average ($6.74). It has closed below the 200-day for 35 sessions, since 17 Sep 2026. The 50-day average crossed below the 200-day on 30 Oct 2026, 3 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Ahead of SPY over 1 year
1 month: +7.8% (SPY −1.6%). 3 months: −7.4% (SPY −0.4%). 1 year: +17.1% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: AURA, SPY · as of 4 Nov 2026
40% of the way up its 52-week range
Closed at $6.65 on 4 Nov 2026: 30.3% below the 52-week high of $9.54 (5 May 2026) and 40.6% above the low of $4.73 (20 Jan 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+7.8%

6 months−19.8%

1 year+17.1%

5 years−63.7%

Newswire

About

Website

Notable moves

November 7, 2023
−32.55%
November 29, 2021
−21.53%
November 16, 2021
+20.24%

Aura Biosciences, Inc.

Aura Biosciences, Inc. in brief

10.6 days to cover short interest

Above its 50-day average, below its 200-day

Ahead of SPY over 1 year

40% of the way up its 52-week range

Aura Biosciences, Inc.

Aura Biosciences, Inc. in brief

10.6 days to cover short interest

Above its 50-day average, below its 200-day

Ahead of SPY over 1 year

40% of the way up its 52-week range